Remedium Capital Partners, LLC — 13F Holdings

2026 Q2  ·  7 Positions

2026 Q2 Portfolio Activity

In 2026 Q2, Remedium Capital Partners, LLC maintained a portfolio of 7 distinct positions. The fund also reduced its exposure to Spyre Therapeutics Inc by 23.2%.
Position History hover any row below to update
Loading…
Remedium Capital Partners, LLC Asset Manager AUM $452M
Fund Overview SEC EDGAR
PCA Score Concentration Risk
Risk ENB
To Excel To CSV
Total Positions
7
Quarter
2026 Q2
Top Holding
ORKA (33.0%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-7 of 7
Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
ORKA
Oruka Therapeut...
Healthcare 32.99% 28.98% #1 1
Prev: #2
6.5
—
-323,454 -17.1%
P
S
1,565,661 $149,003,957
$33.65 +176.8%
$95.17 -2.1%
2025 Q4 13F Filing 2026-06-30 2026-08-07
SYRE
Spyre Therapeut...
Healthcare 28.78% 30.09% #2 1
Prev: #1
5.5
—
-443,158 -23.2%
P
S
1,464,169 $129,988,924 2025 Q4 13F Filing 2026-06-30 2026-08-07
APGE
Apogee Therapeu...
Healthcare 17.24% 15.36% #3 1
Prev: #4
5.5
—
3,100 0.5%
P
S
586,691 $77,871,496 2025 Q4 13F Filing 2026-06-30 2026-08-07
GLTO
Damora Therapeu...
Healthcare 11.78% 16.57% #4 1
Prev: #3
5.5
—
no change no change
P
S
2,045,473 $53,202,753 2025 Q4 13F Filing 2026-06-30 2026-08-07
JBIO
Jade Bioscience...
Healthcare 7.76% 6.93% #5
Prev: #5
4.6
—
no change no change
P
S
1,577,750 $35,057,605 2025 Q4 13F Filing 2026-06-30 2026-08-07
N/A
Crescent Biopha...
Unknown 1.44% — #6
Prev: #—
4.1
—
361,250 —
NEW
 361,250 $6,502,500 — 13F Filing 2026-06-30 2026-08-07
N/A
Crescent Biopha...
Unknown 0.00% 2.08%
Sold All 😨
(Was: #6)
 0.0
—
-361,250 -100.0%
CLOSED
 — $— — 13F Filing 2026-06-30 2026-08-07
Showing 1-7 of 7 holdings

Unlock Full Remedium Capital Partners, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Upgrade to PRO
Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →